Natera (NTRA) Liabilities and Shareholders Equity (2014 - 2026)
Natera's (NTRA) quarterly Liabilities and Shareholders Equity came in at $2.6 billion in Q1 2026, up 50.91% YoY from $1.7 billion in Q1 2025, and up 9.01% on a QoQ basis from $2.4 billion in Q4 2025.
Natera (NTRA) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Natera (NTRA) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $2.6 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 50.91% year-over-year to $2.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 billion (up 32.15% YoY) and the FY2025 annual result came in at $2.4 billion, up 44.41% from the prior year.
- Liabilities and Shareholders Equity rose to $2.6 billion in Q1 2026, from $2.4 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.6 billion in Q1 2026 to a low of $1.0 billion in Q3 2022.
- A 5-year average of $1.6 billion and a median of $1.5 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity dropped 23.05% — and 2026, when it jumped 50.91%.
- Tracing NTRA's Liabilities and Shareholders Equity over 5 years: stood at $1.4 billion in 2022, then climbed by 3.39% to $1.4 billion in 2023, then climbed by 15.19% to $1.7 billion in 2024, then soared by 44.41% to $2.4 billion in 2025, then grew by 9.01% to $2.6 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $2.6 billion (Q1 2026), $2.4 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 3.44 Bn |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 13.07 Bn |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | 29.88 Bn |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 6.65 Bn |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 3.67 Bn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 16.94 Bn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 19.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.61 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 1.82 Bn |
| Jun 30, 2025 | 1.76 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 1.66 Bn |
| Sep 30, 2024 | 1.59 Bn |
| Jun 30, 2024 | 1.52 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.44 Bn |
| Sep 30, 2023 | 1.45 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.32 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Mar 31, 2022 | 1.14 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 1.31 Bn |
| Jun 30, 2021 | 849.96 Mn |